A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
167/199
A61K 31/70 (2006.01) A61K 33/24 (2006.01)
Patent
CA 1314219
Abstract of the Disclosure A novel agent is provided herein for the prevention or prophylaxis of general toxic effects or chronic neurotoxic effects which are caused by the administration of antineoplastic agents, which is to be given to patients prior to administration of said antineoplastic agents and which comprises as an active ingredient a mixture of gangliosides GM1, GD1a, GD1b and GT1b.
540885
Della Valle Francesco
Fidia S.p.a.
Marcus & Associates
LandOfFree
Use of exogenous gangliosides in tumoral diseases as a... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of exogenous gangliosides in tumoral diseases as a..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of exogenous gangliosides in tumoral diseases as a... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1318392